India to United States: Carboplatin Export Trade Route
India has recorded 118 verified shipments of Carboplatin exported to United States, representing a combined trade value of $11.3M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $95.8K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 53% of total export value with 47 shipments worth $6.0M USD. On the buying side, EUGIA US LLC, is the largest importer in United States with $3.1M USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, GLAND PHARMA LIMITED, TEYRO LABS PRIVATE LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Carboplatin corridor is one of India's established pharmaceutical export routes, with 118 shipments documented worth a combined $11.3M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's carboplatin manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $95.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with carboplatin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 27.7%, placing it at rank #19 among India's top carboplatin export destinations globally.
On the import side, key buyers of Indian carboplatin in United States include EUGIA US LLC,, EUGIA US LLC, Chris Lessly and 22 others. EUGIA US LLC, is the single largest importer with 24 shipments valued at $3.1M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ4
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#19
- Annual growth+27.7%
- Demand growth+23.3%
- Regulatory ease88/100
Top 10 Indian Carboplatin Exporters to United States
Showing top 10 of 11 Indian suppliers exporting Carboplatin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $128.5K per shipment | 47 | $6.0M | 53.5% |
| 2 | GLAND PHARMA LIMITED Avg $426.6K per shipment | 10 | $4.3M | 37.8% |
| 3 | TEYRO LABS PRIVATE LIMITED Avg $34.6K per shipment | 27 | $934.6K | 8.3% |
| 4 | SOUTH DELHI PHARMA Avg $15.4K per shipment | 2 | $30.8K | 0.3% |
| 5 | GENEX PHARMA Avg $7.5K per shipment | 1 | $7.5K | 0.1% |
| 6 | ATLAS ENTERPRISES Avg $569 per shipment | 13 | $7.4K | 0.1% |
| 7 | KOIT BIOPHARMA PRIVATE LIMITED Avg $1.2K per shipment | 6 | $7.0K | 0.1% |
| 8 | VEA IMPEX (I) PRIVATE LIMITED Avg $560 per shipment | 9 | $5.0K | 0.0% |
| 9 | VEA IMPEX I PRIVATE LIMITED Avg $364 per shipment | 1 | $364 | 0.0% |
| 10 | VINAYAK ASSOCIATES Avg $310 per shipment | 1 | $310 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting carboplatin to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, GLAND PHARMA LIMITED, TEYRO LABS PRIVATE LIMITED, SOUTH DELHI PHARMA, GENEX PHARMA, ATLAS ENTERPRISES, KOIT BIOPHARMA PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED, VEA IMPEX I PRIVATE LIMITED, VINAYAK ASSOCIATES. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 47 shipments worth $6.0M USD, giving it a 53% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to United States Carboplatin export route.
Top 10 Carboplatin Importers in United States
Showing top 10 of 25 known buyers in United States receiving Carboplatin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian carboplatin in United States include EUGIA US LLC,, EUGIA US LLC, Chris Lessly, XXI LXXS LXX, Nicole Salvi, among 25 total buyers. The largest importer is EUGIA US LLC,, accounting for $3.1M USD across 24 shipments — representing 28% of all carboplatin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA US LLC, | 24 | $3.1M | 27.8% |
| 2 | EUGIA US LLC | 23 | $2.9M | 25.6% |
| 3 | Chris Lessly | 6 | $2.5M | 21.8% |
| 4 | XXI LXXS LXX | 3 | $1.3M | 11.4% |
| 5 | Nicole Salvi | 1 | $509.3K | 4.5% |
| 6 | MSAPOTEX CORP PLAINFIELD | 6 | $428.3K | 3.8% |
| 7 | M/S.APOTEX CORP, PLAINFIELD | 3 | $221.9K | 2.0% |
| 8 | M/S.APOTEX CORP. PLAINFIELD | 14 | $146.7K | 1.3% |
| 9 | M/S.APOTEX CORP. PLAINFEILD | 2 | $74.2K | 0.7% |
| 10 | M S APOTEX CORP PLAINFEILD | 1 | $31.7K | 0.3% |
Showing top 10 of 25 Carboplatin importers in United States on this route.
Top 10 Carboplatin Formulations Imported by United States
Showing top 10 of 80 product formulations shipped on the India to United States Carboplatin route, ranked by trade value
United States imports a wide range of carboplatin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CARBOPLATIN INJECTION 600MG/60ML — accounts for $2.7M USD across 6 shipments. There are 80 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CARBOPLATIN INJECTION 600MG/60ML | 6 | $2.7M | 23.7% |
| 2 | CARBOPLATIN INJECTION 450MG/45ML | 3 | $1.1M | 9.6% |
| 3 | CARBOPLATIN INJECTION 10 MG/ML CARBOPLATIN INJECTION 10 MG/ML 600 MG/60 MLMDV- US ST-SANJA | 4 | $651.8K | 5.8% |
| 4 | CARBOPLATIN INJECTION 600MG/60ML | 1 | $509.3K | 4.5% |
| 5 | CARBOPLATIN INJECTION 10 MG/ML (CARBOPLATIN INJECTION, 10 MG/ML, (600 MG/60 ML)(MDV)- US (ST-SANJA))NOS | 3 | $507.0K | 4.5% |
| 6 | CARBOPLATIN INJECTION 10 MG/ML CARBOPLATIN INJECTION 10 MG/ML 450 MG/45 MLMDV - US ST-SANJA | 3 | $439.9K | 3.9% |
| 7 | CARBOPLATIN INJECTION 10 MG/ML (CARBOPLATIN INJECTION, 10 MG/ML, (600 MG/60 ML)(MDV) - US (ST-SANJA)) | 2 | $398.9K | 3.5% |
| 8 | CARBOPLATIN INJECTION 10 MG/ML CARBOPLATIN INJECTION, 10 MG/ML, 600 MG/60 MLMDV- US ST-SANJA | 1 | $360.4K | 3.2% |
| 9 | CARBOPLATIN INJECTION 10 MG/ML (CARBOPLATIN INJECTION, 10 MG/ML, (600 MG/60 ML)(MDV)- US (ST-SANJA)) | 2 | $348.6K | 3.1% |
| 10 | CARBOPLATIN INJECTION 10 MG/ML (CARBOPLATIN INJECTION, 10 MG/ML, (450 MG/45 ML)(MDV) - US (ST-SANJA)) | 3 | $284.4K | 2.5% |
Showing top 10 of 80 Carboplatin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 25 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's carboplatin exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 47 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, GLAND PHARMA LIMITED, TEYRO LABS PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $95.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as carboplatin injection 450mg/45ml and carboplatin injection 10 mg/ml carboplatin injection 10 mg/ml 600 mg/60 mlmdv- us st-sanja, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EUGIA US LLC, is the largest importer with 24 shipments worth $3.1M USD — representing 28% of all carboplatin imports from India on this route. A total of 25 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $11.3M
- Avg. Shipment
- $95.8K
- Suppliers
- 11
- Buyers
- 25
- Transit (Sea)
- ~27 days
- Annual Growth
- +27.7%
Related Analysis
Reverse Direction
United States → India — Carboplatin (Import)Other Carboplatin Routes
Carboplatin — Export Intelligence Video
Visual overview of India's carboplatin India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Carboplatin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 118 shipments on this route.
Frequently Asked Questions — India to United States Carboplatin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Carboplatin to United States?
The leading Indian exporters of Carboplatin to United States are EUGIA PHARMA SPECIALITIES LIMITED, GLAND PHARMA LIMITED, TEYRO LABS PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 53% of total trade value on this route.
Q What is the total value of Carboplatin exports from India to United States?
India exports Carboplatin to United States worth approximately $11.3M USD across 118 recorded shipments. The average value per shipment is $95.8K USD.
Q Which ports does India use to ship Carboplatin to United States?
The most active port of origin is HYDERABAD AIR with 25 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to United States for Carboplatin?
The average transit time for Carboplatin shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Carboplatin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.7% with demand growth tracking at 23.3%. The route is ranked #19 among India's top Carboplatin export destinations globally.
Q How many suppliers are active on the India to United States Carboplatin route?
There are currently 11 active Indian suppliers exporting Carboplatin to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 53% of total shipment value.
Q Who are the main importers of Carboplatin from India in United States?
The leading importers of Indian Carboplatin in United States include EUGIA US LLC,, EUGIA US LLC, Chris Lessly, XXI LXXS LXX, Nicole Salvi. EUGIA US LLC, is the largest buyer with 24 shipments worth $3.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Carboplatin.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 25 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 118 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
118 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists